Boehringer Ingelheim

Boehringer Ingelheim and Salipro Biotech enter drug development partnership PMLiVE12:47Biotech Pharma Biotechnology

Boehringer Ingelheim and Salipro enter drug discovery partnership Pharmaceutical Technology16:22Biotech Pharma Biotechnology

Boehringer Ingelheim terminates steatohepatitis drug development, returns rights to Yuhan Korea Biomedical Review05:15Pharma

Telekom and Boehringer Ingelheim enhance clinical trials with digital innovation The Fast Mode02:14Pharma Telecoms

With drug Empagliflozin going off patent, doctors look forward to price reduction, benefitting diabetic, heart and… The Hindu11:27Diabetes India Pharma

Key diabetes drug to cost up to 90% less in a few days The Times of India00:22Diabetes Pharma Tirzepatide

Boehringer Ingelheim and Salipro Biotech partner to develop novel therapeutics Manufacturing Chemist12:23Biotech Pharma Biotechnology

Indian pharma cos to launch cheaper diabetes medicine at 90% lower price soon The Economic Times10:38Pharma Diabetes India

Best method challenge continues to offer “a material advantage” – Zoetis services LLC v Boehringer Ingelheim animal… National Law Review23:14Patent Law Intellectual Property Zoetis

New initiative to improve kidney disease screening launched in Hampshire Daily Echo03:52Isle of Wight Pharma Hampshire

Latest News

In the last 4 hours

Best Method Challenge Continues to Offer “a Material Advantage” – Zoetis Services LLC v Boehringer Ingelheim Animal… National Law Review23:14 27-Mar-25

In the last 7 days

Telekom and Boehringer Ingelheim Enhance Clinical Trials with Digital Innovation The Fast Mode02:14 26-Mar-25

In the last month

Anti-Venom Market Forecast Report and Company Analysis 2025-2033 Featuring Bharat Serums and Vaccines, Boehringer… GlobeNewswire (Press Release)16:18 19-Mar-25

Boehringer Ingelheim and Salipro Biotech enter drug development partnership PMLiVE12:47 18-Mar-25

New initiative aims to improve chronic kidney disease screening Basingstoke Gazette07:40 17-Mar-25

Epidermal Growth Factor Receptor Antagonists Research Report 2025: A $18.4 Billion Market by 2032 Featuring Pfizer,… GlobeNewswire (Press Release)16:35 14-Mar-25

Boehringer Ingelheim and Salipro enter drug discovery partnership Pharmaceutical Technology16:22 14-Mar-25

Boehringer Ingelheim and Salipro Biotech partner to develop novel therapeutics Manufacturing Chemist12:23 14-Mar-25

With drug Empagliflozin going off patent, doctors look forward to price reduction, benefitting diabetic, heart and… The Hindu11:27 14-Mar-25

New initiative to improve kidney disease screening launched in Hampshire Daily Echo03:52 14-Mar-25

Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer… GlobeNewswire (Press Release)13:03 13-Mar-25

Boehringer Ingelheim teams with Veeva to launch new R&D platform One Medicine FierceBiotech09:56 12-Mar-25

Boehringer Ingelheim and Cognizant announce the launch of a unified cloud platform to bring… PR Newswire (Press Release)11:07 11-Mar-25

Boehringer Ingelheim Partners with Veeva to Launch 'One Medicine Platform' PR Newswire (Press Release)11:06 11-Mar-25

Indian pharma cos to launch cheaper diabetes medicine at 90% lower price soon The Economic Times10:38 10-Mar-25

Key diabetes drug to cost up to 90% less in a few days The Times of India00:22 10-Mar-25

New analyses on the potential impact of SPEVIGO® in generalized pustular psoriasis… PR Newswire (Press Release)14:09 7-Mar-25

Boehringer Ingelheim terminates steatohepatitis drug development, returns rights to Yuhan Korea Biomedical Review05:15 7-Mar-25

Europe Dog Dewormers Market Report 2025-2030: Zoetis, Boehringer Ingelheim, Merck & Co., Dechra Pharmaceuticals, and… GlobeNewswire (Press Release)15:21 5-Mar-25

Boehringer Ingelheim Malaysia Recognised As A Local Top Employer For Seventh Consecutive Year Bernama13:11 5-Mar-25

NDCs patients to get cheaper drugs in deal The Star, Kenya02:17 4-Mar-25

Boehringer Ingelheim Launches Trivalent Poultry Vaccine, Includes Protection Against H5 Avian Influenza AgriMarketing08:12 3-Mar-25

Kenya: Boehringer, Meds Partner to Expand Diabetes, Hypertension Treatment. AllAfrica15:18 26-Feb-25

Boehringer Ingelheim wins jury verdict in Zantac retrial in Illinois ENDPOINTS19:02 25-Feb-25

CDR-Life Announces Fifth Milestone Achievement with Boehringer Ingelheim in Geographic Atrophy Business Wire (Press Release)13:07 25-Feb-25

Dubai garden blooms with Boehringer Ingelheim’s lung disease campaign PharmaTimes10:26 25-Feb-25

view more headlines

27 Mar 23:14

Boehringer News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Boehringer news, covering the latest share price, company announcements, product trials, pharmaceuticals news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.